Age related secretary pattern of growth hormone, insulin-like growth factor-I & insulin-like growth factor binding protein-3 in postmenopausal women

被引:0
|
作者
Aliasgarzadeh, Akbar [1 ]
Ghojazadeh, Morteza [2 ]
Haji-Hoseini, Reza [3 ]
Mehanfar, Faezeh [4 ]
Piri, Reza [5 ]
Naghavi-Behzad, Mohammad [6 ]
Nezami, Nariman [7 ]
机构
[1] Tabriz Univ Med Sci, Endocrine & Metab Res Ctr, Tabriz, Eastern Azerbai, Iran
[2] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Eastern Azerbai, Iran
[3] Tehran Payame Noor Univ, Dept Biochem, Tehran, Iran
[4] Tabriz Univ Med Sci, Dept Biochem, Tabriz, Eastern Azerbai, Iran
[5] Tabriz Univ Med Sci, Students Res Comm, Tabriz, Eastern Azerbai, Iran
[6] Tabriz Univ Med Sci, Med Philosophy & Hist Res Ctr, Tabriz, Eastern Azerbai, Iran
[7] Johns Hopkins Univ Hosp, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
来源
关键词
Growth hormone; insulin-like growth factor-1; insulin-like growth factor binding protein-3; postmenopausal women; BONE-MINERAL DENSITY; BODY-COMPOSITION; FACTOR (IGF)-I; ROUTE; EXPRESSION; IMPACT; MEN;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: After menopause in women, loss of bone density increases rapidly with estrogen deficiency. Evidence has revealed that this deficiency may be directly correlated with growth hormone (GH) level declining with age. The present study was designed to evaluate the age dependant patterns of GH, insulin-like growth factor-1 (IGF1-1) and insulin-like growth factor binding protein-3 (IGFBP-3) endogenous secretion in postmenopausal women. Methods: During this prospective study in a 12-month period, 150 postmenopausal women were enrolled who were referred to the densitometry unit of bone research centre of Tabriz University of Medical Sciences for assessing bone mineral density. Serum levels of basal and clonidine stimulated GH were measured using radioimmunoassay while IGF-1 and IGFBP-3 were measured by ELISA. Post stimulation over 3 to 6 fold increase in GH over the baseline level was considered normal response and less increase was considered abnormal. Results: There were no significant differences in the mean levels of GH0, GH60 and GH90 in different age groups of postmenopausal women. No significant difference in the mean IGFBP-3 and IGF-1 levels was seen in different age groups of postmenopausal women. The number of postmenopausal women with abnormal response to stimulation by clonidine in 61-70 and > 70 yr age groups was higher than in other groups (P<0.05). Interpretation & conclusions: Despite the higher rate of abnormal response to stimulation by clonidine in women aged more than 60 yr, the current study showed no significant correlation between age, and the basal and stimulated GH secretion rate and serum levels of IGF-1 and IGFBP-3 in postmenopausal women.
引用
收藏
页码:598 / 602
页数:5
相关论文
共 50 条
  • [1] Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3
    Pirazzoli, P
    Cacciari, E
    DeIasio, R
    Pittalis, MC
    Dallacasa, P
    Zucchini, S
    Gualandi, S
    Salardi, S
    David, C
    Boschi, S
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 77 (02): : F100 - F104
  • [2] Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
    Duron, Emmanuelle
    Funalot, Benoit
    Brunel, Nadege
    Coste, Joel
    Quinquis, Laurent
    Viollet, Cecile
    Belmin, Joel
    Jouanny, Pierre
    Pasquier, Florence
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    le Bouc, Yves
    Hanon, Olivier
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4673 - 4681
  • [3] Impaired sensitivity to insulin and insulin-like growth factor-I in insulin-like growth factor binding protein-3 transgenic mice
    Silha, JV
    Gui, Y
    Murphy, LJ
    [J]. DIABETOLOGIA, 2002, 45 : A31 - A31
  • [4] Insulin-like growth factor binding protein-3: Insulin-like growth factor independence comes of age
    Cohen, P
    [J]. ENDOCRINOLOGY, 2006, 147 (05) : 2109 - 2111
  • [5] CHANGES IN ERYTHROCYTE INSULIN-LIKE GROWTH FACTOR-I RECEPTORS, GROWTH-HORMONE BINDING-PROTEIN, INSULIN-LIKE GROWTH FACTOR-I, INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3, AND GROWTH-RATE DURING GROWTH-HORMONE TREATMENT
    MANDEL, S
    MORELAND, E
    HANNA, C
    LAFRANCHI, S
    [J]. CLINICAL RESEARCH, 1994, 42 (01): : A21 - A21
  • [6] Effects of alcohol and menstrual cycle on insulin-like growth factor-I and insulin-like growth factor binding protein-3
    Lavigne, JA
    Wimbrow, HH
    Clevidence, BA
    Albert, PS
    Reichman, ME
    Campbell, WS
    Barrett, JC
    Hursting, SD
    Judd, JT
    Taylor, PR
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (12) : 2264 - 2267
  • [7] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 in premature rupture of membranes
    Loukovaara, M
    Koistinen, R
    Kalme, T
    Kurki, T
    Leinonen, P
    Seppälä, M
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (10) : 905 - 908
  • [8] Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in obese children
    Bideci, A
    Cinaz, P
    Hasanoglu, A
    Elbeg, S
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1997, 10 (03): : 295 - 299
  • [9] Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in ischaemic and idiopathic dilated cardiomyopathy
    Pucci, A
    Zanini, C
    Cresto, LC
    Granata, R
    Migliorino, D
    Broglio, F
    Podio, V
    Di Summa, M
    Graziani, A
    Ghigo, E
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 : 38 - 38
  • [10] Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis
    Toussirot, E
    Nguyen, NU
    Dumoulin, G
    Regnard, J
    Wendling, D
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (11): : 1172 - 1176